Cargando…
Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic
The coronavirus disease-19 (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus that was first detected at the end of December 2019. The epidemic has affected various regions of China in different degrees. As the situations evolve, the COVID-19 had been confirmed in many c...
Autores principales: | Ying, Wang, Qian, Yu, Kun, Zhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136878/ https://www.ncbi.nlm.nih.gov/pubmed/32317153 http://dx.doi.org/10.1016/j.sapharm.2020.04.001 |
Ejemplares similares
-
Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic
por: BenAmor, W. Daoud, et al.
Publicado: (2022) -
Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic
por: Hua, XiaoLi, et al.
Publicado: (2020) -
Application of “Internet +” pharmaceutical consultation services in psychiatric hospital during the epidemic
por: Jiang, Ying, et al.
Publicado: (2023) -
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19
por: McCrae, Karen, et al.
Publicado: (2022) -
Assessment of Inventory Management Practices at the Ethiopian Pharmaceuticals Supply Agency, Addis Ababa, Ethiopia
por: Boche, Bekele, et al.
Publicado: (2020)